PMDD Session Spotlight: Accelerate Proof Of Concept – Making the transition from project management to portfolio management

The 8th Annual Project and Portfolio Management for the Drug and Device Industry, September 20-21st in Boston, Massachusetts, is the only event designed by manufacturers for manufacturers to deliver advanced time saving and silo busting strategies proven to bring drugs and devices to market on time and on budget. Leading up to the event, the Future of Biopharma blog will be spotlighting some of the sessions you can look forward to at the the event.  For more information on the event, download the brochure here.

Session: Accelerate Proof Of Concept – Making the transition from project management to portfolio management

Featured Speaker: Dee Suberla, Sr. Consultant, Action for Results

About the session: Innovation to accelerate the drug development process is a hot topic in the life science industry.  Speeding up the seemingly standard development plan would mean hundreds of millions in cost savings. While there are ways to get a drug registered in the US and ex-US that don’t require that length of time, PMs aren’t currently taking advantage creative ways to accelerate programs.

In this session you will learn to:
• Design and implement an accelerated drug development strategy
• Conduct portfolio prioritization to enable early decision making
• Implement effective development and scenario planning
• Strategize for early decision making in pharma projects
• Establish interim assessment points and futility assessment points

Share this article with your social network, just click below to share now!

Share |